Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Manal F. Abdelmalek"'
Autor:
Kara Wegermann, Marat Fudim, Ricardo Henao, Catherine F. Howe, Robert McGarrah, Cynthia Guy, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 14 (2023)
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure with preserved ejection fraction (HFpEF) share common risk factors, including obesity and diabetes. They are also thought to be mechanistically linked. The aim of this study was to
Externí odkaz:
https://doaj.org/article/b039730bdfb84d48a651f270b0cc3361
Autor:
Anthony E. Peters, Ambarish Pandey, Colby Ayers, Kara Wegermann, Robert W. McGarrah, Justin L. Grodin, Manal F. Abdelmalek, Tarek Bekfani, Vanessa Blumer, Anna Mae Diehl, Cynthia A. Moylan, Marat Fudim
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 842-848 (2021)
Abstract Aims Non‐alcoholic fatty liver disease leads to progressive liver fibrosis and appears to be a frequent co‐morbid disease in heart failure with preserved ejection fraction (HFpEF). It is well known that liver fibrosis severity predicts f
Externí odkaz:
https://doaj.org/article/e67e539858ad4fc2b3ae455e47041b95
Autor:
Marat Fudim, Lin Zhong, Kershaw V. Patel, Rohan Khera, Manal F. Abdelmalek, Anna Mae Diehl, Robert W. McGarrah, Jeroen Molinger, Cynthia A. Moylan, Vishal N. Rao, Kara Wegermann, Ian J. Neeland, Ethan A. Halm, Sandeep R. Das, Ambarish Pandey
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejec
Externí odkaz:
https://doaj.org/article/0348b254322045d6b98f37ff6e5d05af
Autor:
Colby Ayers, Kara Wegermann, Vanessa Blumer, Robert W. McGarrah, Ambarish Pandey, Cynthia A. Moylan, Anna Mae Diehl, Tarek Bekfani, Anthony E. Peters, Manal F. Abdelmalek, Marat Fudim, Justin L. Grodin
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 842-848 (2021)
ESC Heart Failure
ESC Heart Failure
Aims Non‐alcoholic fatty liver disease leads to progressive liver fibrosis and appears to be a frequent co‐morbid disease in heart failure with preserved ejection fraction (HFpEF). It is well known that liver fibrosis severity predicts future liv
Autor:
Danielle Brandman, Marie Boyle, Stuart McPherson, Mark L. Van Natta, Arun J. Sanyal, Kris Kowdley, Brent Neuschwander‐Tetri, Naga Chalasani, Manal F. Abdelmalek, Norah A. Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E. Kleiner, Cynthia Behling, James Tonascia, Quentin M. Anstee, Rohit Loomba
Publikováno v:
Alimentary Pharmacology & Therapeutics. 56:182-183
Autor:
Rohan Khera, Kara Wegermann, Manal F. Abdelmalek, Kershaw V. Patel, Lin Zhong, Cynthia A. Moylan, Anna Mae Diehl, Robert W. McGarrah, Vishal N. Rao, Ethan A. Halm, Ian J. Neeland, Marat Fudim, Ambarish Pandey, Sandeep R Das, Jeroen Molinger
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejec
Autor:
Anna Mae Diehl, Ning-Ping Zhang, Ying Wang, Chen Yang, Xiuping Liu, Xue-Jing Liu, Wen‐Yue Dong, Chang Liu, Li Xie, Manal F. Abdelmalek, Jian Wu, Chenjian Gu, Kuo Du, Chen Niu
Publikováno v:
Liver Int
Background and aims Treatment of non-alcoholic steatohepatitis (NASH) is challenging, because suppressing fibrotic progression has not been achieved consistently by drug candidates currently in clinical trials. The aim of this study was to investigat
Autor:
Xue‐Jing Liu, Li Xie, Kuo Du, Chang Liu, Ning‐Ping Zhang, Chen‐Jian Gu, Ying Wang, Manal F. Abdelmalek, Wen‐Yue Dong, Xiu‐Ping Liu, Chen Niu, Chen Yang, Anna Mae Diehl, Jian Wu
Publikováno v:
Liver International. 40
Autor:
Cynthia D. Guy, Lixin Zhu, Ruixin Zhu, Patrizia Farci, Wensheng Liu, Sugantha Govindarajan, Fausto Zamboni, Dingfeng Wu, Susan S. Baker, Zhiwei Cao, Anna Mae Diehl, Manal F. Abdelmalek, Cynthia A. Moylan, Robert D. Baker, Weili Lin
Publikováno v:
The Journal of Pathology. 238:531-542
Obese animals and non-alcoholic fatty liver disease (NAFLD) patients exhibit elevated blood alcohol, suggesting potential contributions of alcohol metabolism to the development of NAFLD. Liver gene expression in patients with biopsy-proven mild (N =
Autor:
Brian L. Wiens, Jeffrey Vest, Guruprasad P. Aithal, Arun J. Sanyal, Star Seyedkazemi, Vincent Wai-Sun Wong, Zachary Goodman, Laurent Fischer, Rohit Loomba, Eric Lefebvre, Vlad Ratziu, Frank Tacke, Kris V. Kowdley, Geoffrey C. Farrell, Manal F. Abdelmalek, Pamela Vig, Liza Melchor-Khan, Antonio Craxì, Scott L. Friedman, Krzysztof Simon, Juan Caballería, Stephen A. Harrison, Sven Francque
Publikováno v:
Hepatology (Baltimore, Md.), vol 67, iss 5
Hepatology
Hepatology (Baltimore, Md.)
Hepatology
Hepatology (Baltimore, Md.)
The aim of this study was to evaluate cenicriviroc (CVC), a dual antagonist of C-C chemokine receptor types 2 and 5, for treatment of nonalcoholic steatohepatitis (NASH) with liver fibrosis. A randomized, double-blind, multinational phase 2b study en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd279267e63b246d0eb39c5941a3a85b
https://nottingham-repository.worktribe.com/file/927093/1/Friedman_et_al-2018-Hepatology.pdf
https://nottingham-repository.worktribe.com/file/927093/1/Friedman_et_al-2018-Hepatology.pdf